drugset / Trial / NCT03756623
Effect of Metformin and Probiotics on Gut Microbiome in Healthy Subjects
Completed
90 enrolled
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
RandomizedParallel-groupQuadruple-blindBasic science
Summary
This clinical trial is designed to evaluate the alteration of gut microbiome in healthy subjects after a 12-week metformin and/or probiotics administration.
Timeline
- Start
- 2018-06-01
- Primary completion
- 2019-03-31
- Completion
- 2019-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 0.5 g | Oral |
Indications
No indication recorded.